As of 2026-09-26, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 21.7x | 18.1x |
| Forward P/E multiples | 17.3x - 20.5x | 18.8x |
| Fair Price | (12.57) - (14.95) | (13.45) |
| Upside | -22145.3% - -26333.8% | -23702.9% |
| Date | EV/EBITDA |